Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 12.39% is 300% above its 5-year average of 3.10%, near the high end of its 5-year range (-119.96%–37.57%).
As of the fiscal period ended Tuesday, March 31, 2026. 19.67% below its 12-month average of 15.42%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
12.39%
EBITDA MARGIN AVG TTM
15.42%
EBITDA MARGIN AVG 3Y
11.72%
EBITDA MARGIN AVG 5Y
15.55%
EBITDA MARGIN AVG 10Y
15.24%
EBITDA MARGIN AVG 15Y
17.53%
EBITDA MARGIN AVG 20Y
18.00%
CURRENT VS TTM AVG
-19.67%
CURRENT VS 3Y AVG
+5.73%
CURRENT VS 5Y AVG
-20.35%
CURRENT VS 10Y AVG
-18.75%
CURRENT VS 15Y AVG
-29.35%
CURRENT VS 20Y AVG
-31.17%
DENTSPLY SIRONA Inc.
Market Cap
$2.77B
EBITDA Margin
12.39%
TTM Avg
15.42%
3Y Avg
11.72%
5Y Avg
15.55%
Market Cap
$2.61B
EBITDA Margin
22.42%
TTM Avg
17.70%
3Y Avg
-0.76%
5Y Avg
-37.34%
Market Cap
$1.68B
EBITDA Margin
3.96%
TTM Avg
-13.21%
3Y Avg
-146.19%
5Y Avg
-104.68%
Market Cap
$501.04M
EBITDA Margin
-48.80%
TTM Avg
-44.09%
3Y Avg
-45.35%
5Y Avg
-45.35%
Market Cap
$15.31M
EBITDA Margin
-114.42%
TTM Avg
-123.66%
3Y Avg
-106.79%
5Y Avg
-92.91%
Market Cap
$6.15B
EBITDA Margin
6.82%
TTM Avg
6.08%
3Y Avg
-0.44%
5Y Avg
-8.67%
Market Cap
$7.39B
EBITDA Margin
-18.44%
TTM Avg
-56.37%
3Y Avg
-54.16%
5Y Avg
-65.42%
Market Cap
$7.92B
EBITDA Margin
-3.14%
TTM Avg
-1.08%
3Y Avg
-5.02%
5Y Avg
-19.32%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DENTSPLY SIRONA Inc. (XRAY) | $2.77B | 12.39% | 15.42% | 11.72% | 15.55% |
| TransMedics Group, Inc. (TMDX)vs › | $2.61B | 22.42% | 17.70% | -0.76% | -37.34% |
| Teladoc Health, Inc. (TDOC)vs › | $1.68B | 3.96% | -13.21% | -146.19% | -104.68% |
| Shoulder Innovations, Inc. (SI)vs › | $501.04M | -48.80% | -44.09% | -45.35% | -45.35% |
| NRC Health (NRC)vs › | $477.55M | 21.99% | 25.40% | 28.98% | 31.97% |
| 23andMe Holding Co. (ME)vs › | $15.31M | -114.42% | -123.66% | -106.79% | -92.91% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.15B | 6.82% | 6.08% | -0.44% | -8.67% |
| Tempus AI, Inc. (TEM)vs › | $7.39B | -18.44% | -56.37% | -54.16% | -65.42% |
| Oscar Health, Inc. (OSCR)vs › | $7.92B | -3.14% | -1.08% | -5.02% | -19.32% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.04B | 18.42% | 17.41% | 19.12% | 20.05% |
Gross Margin
48.9%
EBITDA Margin
12.4%
Operating Margin
5.9%
Net Margin
-17.1%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | 12.39% |
| 2025-12-31 | 37.57% |
| 2025-09-30 | 15.27% |
| 2025-06-30 | -4.27% |
| 2025-03-31 | 16.15% |
| 2024-12-31 | -46.52% |
| 2024-09-30 | -39.22% |
| 2024-06-30 | 13.82% |
| 2024-03-31 | 13.43% |
| 2023-12-31 | 15.61% |
| 2023-09-30 | -15.63% |
| 2023-06-30 | 16.15% |
| 2023-03-31 | 8.38% |
| 2022-12-31 | 14.65% |
| 2022-09-30 | -119.96% |
| 2022-06-30 | 19.75% |
| 2022-03-31 | 18.68% |
| 2021-12-31 | 21.97% |
| 2021-09-30 | 20.87% |
| 2021-06-30 | 22.79% |
| 2021-03-31 | 23.20% |
| 2020-12-31 | 20.60% |
| 2020-09-30 | 18.12% |
| 2020-06-30 | -4.89% |
| 2020-03-31 | -5.26% |
| 2019-12-31 | 19.33% |
| 2019-09-30 | 19.55% |
| 2019-06-30 | 14.89% |
| 2019-03-31 | 13.78% |
| 2018-12-31 | 15.05% |
| 2018-09-30 | 13.97% |
| 2018-06-30 | -102.52% |
| 2018-03-31 | 15.89% |
| 2017-12-31 | -59.34% |
| 2017-09-30 | 18.67% |
| 2017-06-30 | -97.73% |
| 2017-03-31 | 17.80% |
| 2016-12-31 | 20.97% |
| 2016-09-30 | 21.25% |
| 2016-06-30 | 19.24% |
| 2016-03-31 | 15.27% |
| 2015-12-31 | 18.12% |
| 2015-09-30 | 20.40% |
| 2015-06-30 | 16.65% |
| 2015-03-31 | 19.49% |
| 2014-12-31 | 18.49% |
| 2014-09-30 | 20.08% |
| 2014-06-30 | 20.91% |
| 2014-03-31 | 19.11% |
| 2013-12-31 | 17.13% |
| 2013-09-30 | 19.33% |
| 2013-06-30 | 20.46% |
| 2013-03-31 | 17.24% |
| 2012-12-31 | 17.21% |
| 2012-09-30 | 16.83% |
| 2012-06-30 | 18.57% |
| 2012-03-31 | 17.13% |
| 2011-12-31 | 11.72% |
| 2011-09-30 | 10.75% |
| 2011-06-30 | 19.12% |
| 2011-03-31 | 20.36% |
| 2010-12-31 | 19.67% |
| 2010-09-30 | 19.62% |
| 2010-06-30 | 21.48% |
| 2010-03-31 | 19.62% |
| 2009-12-31 | 20.96% |
| 2009-09-30 | 10.67% |
| 2009-06-30 | 10.82% |
| 2009-03-31 | 20.23% |
| 2008-12-31 | 19.45% |
| 2008-09-30 | 18.12% |
| 2008-06-30 | 21.39% |
| 2008-03-31 | 20.55% |
| 2007-12-31 | 20.33% |
| 2007-09-30 | 19.47% |
| 2007-06-30 | 20.87% |
| 2007-03-31 | 19.91% |
| 2006-12-31 | 19.41% |
| 2006-09-30 | 20.83% |
| 2006-06-30 | 20.72% |
| 2006-03-31 | 19.05% |
| 2005-12-31 | -2.39% |
| 2005-09-30 | -10.60% |
| 2005-06-30 | 21.30% |
| 2005-03-31 | 20.53% |
| 2004-12-31 | 19.89% |
| 2004-09-30 | 20.52% |
| 2004-06-30 | 20.95% |
| 2004-03-31 | 20.01% |
| 2003-12-31 | 21.98% |
| 2003-09-30 | 19.30% |
| 2003-06-30 | 20.08% |
| 2003-03-31 | 18.71% |
| 2002-12-31 | 19.79% |
| 2002-09-30 | 19.68% |
| 2002-06-30 | 20.52% |
